Germany’s Merck has signed a definitive agreement to acquire Exelead, a US biopharmaceutical CDMO, for around $780 million in cash. The Indianapolis, Indiana-based...
The Life Science business segment of Germany’s Merck has won a €121 million US government contract to build a new plant for its “Hi-Flow" Plus lateral flow membranes used...
Germany’s Merck is allocating an additional €600 million to its strategic corporate venture capital arm M Ventures. The chemicals, pharmaceuticals and life sciences group...
MilliporeSigma, part of the German Merck group, has agreed to provide CDMO services for SaudiVax. The Merck offshoot will design a multi-modality manufacturing plant for...
German pharmaceuticals, chemicals and life sciences group Merck has launched new technology and a capacity expansion to advance development of antibody-drug conjugate...
Özlem Türeci and Uğur Şahin, founders and managing board members of Mainz-based BioNTech, were inducted into the Hall of Fame of German Research (Hall of Fame der...
Germany’s Merck has opened its second production facility for viral vectors at Carlsbad, California, a move the company said significantly expands its global CDMO...
German pharmaceuticals, chemicals and life sciences group Merck has started up a second production line for silica-based effect pigments at its Gernsheim, Germany, site...
